KALV NASDAQ
KalVista Pharmaceuticals, Inc.
1W: +0.0%
1M: +36.9%
3M: +69.1%
YTD: +73.2%
1Y: +118.7%
3Y: +166.4%
5Y: +2.7%
$26.79
+0.02 (+0.07%)
Weekly Expected Move ±19.9%
$16
$21
$27
$32
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
+0.0% YoY
$-203M
Net Income
-43.3% YoY
$-167M
Free Cash Flow
-62.7% YoY
58.6%
Gross Margin
-4138.1%
Op. Margin
-4214.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-134.5%
ROA-83.5%
ROIC186.4%
Valuation
P/E-9.8
P/B-499.4
EV/EBITDA-2.8
Leverage
Debt/Equity0.07
Current Ratio5.35
Interest Cov.-21.1x
Quality Scores
Piotroski F3/9
Altman Z-2.47
Beneish M0.00